End-of-day quote
Korea S.E.
18:00:00 2024-04-25 EDT
|
5-day change
|
1st Jan Change
|
4,045
KRW
|
+0.50%
|
|
+6.59%
|
-3.11%
|
02-08 |
EOFLOW Co.,Ltd. announced that it has received KRW 17 billion in funding from DB Financial Investment Co., Ltd., Samsung Securities Co., Ltd., NH Investment & Securities Co., Ltd., Tiger Investment Advisory Co.,Ltd., Hana Investment Banking & Securities Inc., Investment Arm
|
CI
| 2023 |
EOFLOW Co.,Ltd. cancelled the transaction announced on May 25, 2023
|
CI
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
818,341
|
566,941
|
454,553
|
126,990
|
Enterprise Value (EV)
1 |
798,551
|
571,806
|
416,432
|
124,841
|
P/E ratio
|
-36.8
x
|
-18.9
x
|
-14.6
x
|
-2.05
x
|
Yield
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
37,791
x
|
818
x
|
67.8
x
|
19.3
x
|
EV / Revenue
|
36,877
x
|
825
x
|
62.1
x
|
18.9
x
|
EV / EBITDA
|
-67.5
x
|
-22.7
x
|
-12.8
x
|
-3.68
x
|
EV / FCF
|
-102
x
|
-19.8
x
|
-10.4
x
|
-6.11
x
|
FCF Yield
|
-0.98%
|
-5.06%
|
-9.59%
|
-16.4%
|
Price to Book
|
33
x
|
31.5
x
|
4.61
x
|
2.43
x
|
Nbr of stocks (in thousands)
|
22,513
|
23,140
|
30,304
|
30,417
|
Reference price
2 |
36,350
|
24,500
|
15,000
|
4,175
|
Announcement Date
|
21-03-17
|
22-03-21
|
23-03-22
|
24-03-19
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
21.65
|
693.3
|
6,708
|
6,589
|
EBITDA
1 |
-11,825
|
-25,179
|
-32,503
|
-33,912
|
EBIT
1 |
-12,858
|
-26,992
|
-35,584
|
-39,377
|
Operating Margin
|
-59,379.05%
|
-3,893.41%
|
-530.48%
|
-597.6%
|
Earnings before Tax (EBT)
1 |
-19,647
|
-29,988
|
-31,298
|
-62,315
|
Net income
1 |
-19,647
|
-29,750
|
-30,711
|
-61,936
|
Net margin
|
-90,729.49%
|
-4,291.24%
|
-457.84%
|
-939.95%
|
EPS
2 |
-988.7
|
-1,297
|
-1,025
|
-2,038
|
Free Cash Flow
1 |
-7,824
|
-28,912
|
-39,934
|
-20,429
|
FCF margin
|
-36,132.44%
|
-4,170.45%
|
-595.32%
|
-310.03%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
Announcement Date
|
21-03-17
|
22-03-21
|
23-03-22
|
24-03-19
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
4,866
|
-
|
-
|
Net Cash position
1 |
19,790
|
-
|
38,120
|
2,149
|
Leverage (Debt/EBITDA)
|
-
|
-0.1932
x
|
-
|
-
|
Free Cash Flow
1 |
-7,824
|
-28,912
|
-39,934
|
-20,429
|
ROE (net income / shareholders' equity)
|
-139%
|
-137%
|
-53.2%
|
-79.1%
|
ROA (Net income/ Total Assets)
|
-41%
|
-36.7%
|
-20.7%
|
-21.1%
|
Assets
1 |
47,881
|
80,956
|
148,387
|
293,107
|
Book Value Per Share
2 |
1,103
|
777.0
|
3,253
|
1,721
|
Cash Flow per Share
2 |
298.0
|
284.0
|
437.0
|
486.0
|
Capex
1 |
1,199
|
11,691
|
9,020
|
10,419
|
Capex / Sales
|
5,537.83%
|
1,686.31%
|
134.47%
|
158.12%
|
Announcement Date
|
21-03-17
|
22-03-21
|
23-03-22
|
24-03-19
|
|
1st Jan change
|
Capi.
|
---|
| -3.11% | 89.39M | | +73.17% | 12.38B | | -18.74% | 7.92B | | +16.15% | 7.2B | | +4.81% | 5.84B | | +5.99% | 5.07B | | +27.07% | 4.53B | | -21.67% | 3.88B | | -40.82% | 2.23B | | +1.49% | 2.02B |
Medical Equipment
|